Franz Obermayr

Amministratore Delegato presso Panoptes Pharma GmbH

55 anni

Health Technology

Retail Trade

Profilo

Franz Obermayr is the founder and Chief Executive Officer of Panoptes Pharma GmbH since 2013.
He was also the Head of Clinical Development at Nabriva Therapeutics Plc from 2009 to 2013.
In addition, he served as Director of Drug Discovery at GPC Biotech, Inc. Dr. Obermayr was also the Executive Vice President of Clinical Development at Kiora Pharmaceuticals, Inc. in 2021.

Posizioni attive di Franz Obermayr

Società	Posizione	Inizio
Panoptes Pharma GmbH Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria.	Amministratore Delegato	01/07/2013

Tutte le posizioni attive di Franz Obermayr

Precedenti posizioni note di Franz Obermayr

Società	Posizione	Fine
KIORA PHARMACEUTICALS, INC.	Amministratore Delegato	26/07/2021
NABRIVA THERAPEUTICS PLC	Corporate Officer/Principal	01/01/2013
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Franz Obermayr

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Franz Obermayr

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
KIORA PHARMACEUTICALS, INC.	Health Technology
NABRIVA THERAPEUTICS PLC	Health Technology

Aziende private	2
Panoptes Pharma GmbH Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria.	Health Technology
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Retail Trade